Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

Overview of attention for article published in Hepatic medicine evidence and research, March 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 115)
Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

policy: 1 policy source
facebook: 1 Facebook page

wikipedia: 8 Wikipedia pages

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 93 Mendeley

Summary Policy documents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Global report on access to hepatitis C treatment. Focus on overcoming barriers

Cited by World Health Organization on 26 Oct 2016

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.